John Nosenzo

John Nosenzo is a declared insider at 2 companies (senior executive); the most frequent names are Bioventus Inc. and TELA Bio, Inc. The record holds 12 filings, for trades running from 11 February 2021 to 1 June 2023.

Market trades split into 1 purchase (€5,362) and 5 sales (€675k). Taken together, the sales exceed the purchases by €670k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants and 3 option exercises. Since January 2023: no purchases and 3 sales on the market.

Most recently, on 2 June 2023, the filings show a share grant in TELA Bio, Inc. The last purchase on record was published on 5 April 2021, which is 2,044 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.